NASDAQ: SVRA

Savara Inc Stock Forecast, Predictions & Price Target

The consensus among 4 Wall Street analysts covering (NASDAQ: SVRA) stock is to Strong Buy SVRA stock.

Out of 4 analysts, 2 (50%) are recommending SVRA as a Strong Buy, 2 (50%) are recommending SVRA as a Buy, 0 (0%) are recommending SVRA as a Hold, 0 (0%) are recommending SVRA as a Sell, and 0 (0%) are recommending SVRA as a Strong Sell.

If you're new to stock investing, here's how to buy Savara stock.

(NASDAQ: SVRA) Savara's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Savara's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast SVRA's revenue for 2025 to be $3,158,066,503, with the lowest SVRA revenue forecast at $3,158,066,503, and the highest SVRA revenue forecast at $3,158,066,503. On average, 3 Wall Street analysts forecast SVRA's revenue for 2026 to be $7,046,936,672, with the lowest SVRA revenue forecast at $5,622,629,339, and the highest SVRA revenue forecast at $9,825,095,788.

In 2027, SVRA is forecast to generate $16,776,295,799 in revenue, with the lowest revenue forecast at $11,621,021,621 and the highest revenue forecast at $24,091,654,309.

According to 4 Wall Street analysts that have issued a 1 year SVRA price target, the average SVRA price target is $9.25, with the highest SVRA stock price forecast at $16.00 and the lowest SVRA stock price forecast at $6.00.

On average, Wall Street analysts predict that Savara's share price could reach $9.25 by Apr 19, 2025. The average Savara stock price prediction forecasts a potential upside of 97.23% from the current SVRA share price of $4.69.

(NASDAQ: SVRA) forecast ROE is N/A, which is considered weak.